Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 41, 2013 - Issue 4
Submit an article Journal homepage
582
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Preparation and evaluations in vitro of oxaliplatin polylactic acid nanoparticles

Zhaoyuan CuiFaculty of Pharmacy, Medical College of Qingdao University, Qingdao, P.R. China
,
Yong SunFaculty of Pharmacy, Medical College of Qingdao University, Qingdao, P.R. ChinaCorrespondence[email protected]
,
Xiaohong LiuFaculty of Pharmacy, Medical College of Qingdao University, Qingdao, P.R. China
,
Fang JuDepartment of Oncology, Qingdao Central Hospital, Qingdao, P.R. China
,
Qian ChenFaculty of Pharmacy, Medical College of Qingdao University, Qingdao, P.R. China
,
Wen GaoFaculty of Pharmacy, Medical College of Qingdao University, Qingdao, P.R. China
&
Haitian WeiFaculty of Pharmacy, Medical College of Qingdao University, Qingdao, P.R. China
 show all
Pages 227-231 | Received 17 Oct 2012, Accepted 10 Nov 2012, Published online: 10 Jan 2013

References

  • Feng SS, Huang GF. 2001. Effects of emulsifiers on the controlled release of paclitaxel (Taxo1) from nanospheres of biodegradable polymers. J Control Release. 71:53–69.
  • Graham J, Mushin M, Kirkpatrick P. 2004. Oxaliplatin. Nat Rev Drug Discov. 3:11–12.
  • Lee WC, Li YC, Chu IM. 2006. Amphiphilic poly(D,L-lactic acid)/poly(ethylene glycol)/poly(D,L-lactic acid) nanogels for controlled release of hydrophobic drugs. Macromol Biosci. 6: 846–854.
  • Liu MX, Ma L, Liu YQ, Zh Q. 2003. Preparation and characterization of biodegradable poly (lactic acid) nanoparticles. Chem World. 44:78–80.
  • Lu HX, Xu CJ, Li B, Kang Y, Huang Q, Li LM, Chen QH. 2006. The inhibitory effect of paclitaxel nanoparticles on ovarian cancer xenografts and lymphatic targeting. Beijing Da Xue Xue Bao. 38:483–486.
  • Mahapatro A, Singh DK. 2011. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnology. 9:55.
  • Mansour HM, Rhee YS, Wu X. 2009. Nanomedicine in pulmonary delivery. Int J Nanomedicine. 4:299–319.
  • Matsumura Y, Maeda H. 1986. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46:6387–6392.
  • Vasey PA, Kaye SB, Morrison R, Twelves C, Wilson P, Duncan R, et al. 1999. Phase I clinical and pharmacokinetic study of PK1[N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. Clin Cancer Res. 5:83–94.
  • Yang K, Wen Y, Wang C. 2003. The study of cucurbitacin BE polylactic acid nanoparticles delivering cucurbitacin BE to metastasized cervical lymph nodes in mice with oral cancer. Hua Xi Kou Qiang Yi Xue Za Zhi. 21:477–480.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.